GlassScriptPhysician profile
Michelle Bruno
NPI 1366165136
$2,931.06
in general payments reported to CMS, 2019-2025
26 companies · $804 in 2025
The $804 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $427 · 2024: $1,700 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,931.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $528.00 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $504.59 | 2024 | Jot Dx, Gallant, Mitraclip |
| Boston Scientific Corporation | $278.09 | 2024-2025 | General - Crm_crm, Watchman |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.51 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $156.57 | 2024-2025 | Airsupra, Farxiga |
| Corcept Therapeutics | $124.98 | 2025 | Korlym |
| Abbvie INC. | $123.92 | 2023 | |
| Glaxosmithkline, LLC. | $123.87 | 2024 | Arexvy |
| Horizon Therapeutics Plc | $112.95 | 2023 | Krystexxa |
| Pfizer INC. | $112.87 | 2024-2025 | |
| Novo Nordisk INC | $82.52 | 2024-2025 | Wegovy, Ozempic |
| Merck Sharp & Dohme LLC | $71.75 | 2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.32 | 2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $49.54 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $45.07 | 2024 | Arcalyst |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicomp INC | $44.88 | 2024 | Telepatch Cardiac Monitor |
| Lilly USA, LLC | $35.16 | 2024-2025 | Mounjaro, Trulicity, Zepbound |
| Novartis Pharmaceuticals Corporation | $34.67 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.39 | 2025 | |
| Tactile Systems Technology INC | $27.89 | 2025 | Nimbl, Flexitouch Plus |
| Baxter Healthcare | $22.91 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic, INC. | $21.79 | 2025 | Reveal Linq |
| Atricure, INC. | $21.58 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $21.14 | 2024 | |
| Irhythm Technologies, INC. | $20.47 | 2024 | Zio Monitor, Zio Xt Patch |
| Regeneron Healthcare Solutions, INC. | $15.63 | 2025 | Evkeeza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.